Ocean Biomedical Inc (NASDAQ:OCEA) shares, rose in value on Wednesday, April 16, with the stock price down by -1.82% to the previous day’s close as strong demand from buyers drove the stock to $0.04.
Actively observing the price movement in the last trading, the stock closed the session at $0.04, falling within a range of $0.0411 and $0.0432. The value of beta (5-year monthly) was 1.627. Referring to stock’s 52-week performance, its high was $2.09, and the low was $0.04. On the whole, OCEA has fluctuated by -26.53% over the past month.
With the market capitalization of Ocean Biomedical Inc currently standing at about $7.17 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2024-Apr-14.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that OCEA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of OCEA currently trading nearly -20.31% and -50.50% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 32.93, while the 7-day volatility ratio is showing 13.16% which for the 30-day chart, stands at 23.60%. Furthermore, Ocean Biomedical Inc (OCEA)’s beta value is 1.66, and its average true range (ATR) is 0.01.
A comparison of Ocean Biomedical Inc (OCEA) with its peers suggests the former has fared considerably weaker in the market. OCEA showed an intraday change of -1.82% in last session, and over the past year, it shrunk by -97.73%%.
Data on historical trading for Ocean Biomedical Inc (NASDAQ:OCEA) indicates that the trading volumes over the past 10 days have averaged 8.89 and over the past 3 months, they’ve averaged 55.22 million. According to company’s latest data on outstanding shares, there are 166.01 million shares outstanding.
Nearly 16.22% of Ocean Biomedical Inc’s shares belong to company insiders and institutional investors own 2.27% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 2.93 million shares as on 2025-03-31, resulting in a short ratio of 0.05. According to the data, the short interest in Ocean Biomedical Inc (OCEA) stood at 250.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 5.72 million. The stock has fallen by -92.19% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the OCEA stock heading into the next quarter.
